Abstract
The p53 tumour suppressor is a short-lived protein that is maintained at low levels in normal cells by Mdm2-mediated ubiquitination and subsequent proteolysis1,2,3. Stabilization of p53 is crucial for its tumour suppressor function1,2,3,4,5. However, the precise mechanism by which ubiquitinated p53 levels are regulated in vivo is not completely understood. By mass spectrometry of affinity-purified p53-associated factors, we have identified herpesvirus-associated ubiquitin-specific protease6 (HAUSP) as a novel p53-interacting protein. HAUSP strongly stabilizes p53 even in the presence of excess Mdm2, and also induces p53-dependent cell growth repression and apoptosis. Significantly, HAUSP has an intrinsic enzymatic activity that specifically deubiquitinates p53 both in vitro and in vivo. In contrast, expression of a catalytically inactive point mutant of HAUSP in cells increases the levels of p53 ubiquitination and destabilizes p53. These findings reveal an important mechanism by which p53 can be stabilized by direct deubiquitination and also imply that HAUSP might function as a tumour suppressor in vivo through the stabilization of p53.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Ashcroft, M. & Vousden, K. H. Regulation of p53 stability. Oncogene 18, 7637–7643 (1999)
Oren, M. Regulation of the p53 tumour suppressor protein. J. Biol. Chem 274, 36031–36034 (1999)
Freedman, D. A., Wu, L. & Levine, A. J. Functions of the MDM2 oncoprotein. Cell Mol. Life Sci. 55, 96–107 (1999)
Prives, C. & Hall, P. A. The p53 pathway. J. Pathol. 187, 112–126 (1999)
Vogelstein, B., Lane, D. & Levine, A. J. Surfing the p53 network. Nature 408, 307–310 (2000)
Everett, R. D. et al. A novel ubiquitin-specific protease is dynamically associated with the PML nuclear domain and binds to a herpesvirus regulatory protein. EMBO J. 16, 566–577 (1997)
Hershko, A., Ciechanover, A. & Varshavsky, A. The ubiquitin system. Nature Med. 6, 1073–1081 (2000)
Laney, J. D. & Hochstrasser, M. Substract targeting in the ubiquitin system. Cell 97, 427–430 (1999)
Kornitzer, D. & Ciechanover, A. Modes of regulation of ubiquitin-mediated protein degradation. J. Cell. Physiol. 182, 1–11 (2000)
Scheffner, M., Huibregt, J. M., Vierstra, R. D. & Howley, P. The HPV-16 E6 and E6-AP complex functions as an ubiquitin-protein ligase in the ubiquitinnation of p53. Cell 75, 495–505 (1993)
Haupt, Y., Maya, R., Kazaz, A. & Oren, M. Mdm2 promotes the rapid degradation of p53. Nature 387, 296–299 (1997)
Kubbutat, M. H. G., Jones, S. N. & Vousden, S. N. Regulation of p53 stability by Mdm2. Nature 387, 299–303 (1997)
Honda, R., Tanaka, H. & Yasuda, H. Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53. FEBS Lett. 420, 25–27 (1997)
Shieh, S. Y., Ikeda, M., Taya, Y. & Prives, C. DNA damage-induced phosphorylation of p53 alleviates inhibition MDM2. Cell 91, 325–334 (1997)
Appella, E. & Anderson, C. W. Signaling to p53: breaking the posttranslational modification code. Pathol. Biol. (Paris) 48, 227–245 (2000)
Ashcroft, M., Kubbutat, M. H. & Vousden, K. H. Regulation of p53 function and stability by phosphorylation. Mol. Cell. Biol. 19, 1751–1758 (1999)
Blattner, C., Tobiasch, E., Litfen, M., Rahmsdorf, H. J. & Herrlich, P. DNA damage induced p53 stabilization: no indication for an involvement of p53 phosphorylation. Oncogene 18, 1723–1732 (1999)
Dumaz, N. & Meek, D. W. Serine15 phosphorylation stimulates p53 transactivation but does not directly influence interaction with HDM2. EMBO J. 18, 7002–7010 (1999)
Ashcroft, M., Taya, Y. & Vousden, K. H. Stress signals utilize multiple pathways to stabilize p53. Mol. Cell. Biol. 20, 3224–3233 (2000)
Sherr, C. J. & Webber, J. D. The ARF/p53 pathway. Curr. Opin. Genet. Dev. 10, 94–99 (2000)
Gu, W., Shi, X. L. & Roeder, R. G. Synergistic activation of transcription by CBP and p53. Nature 387, 819–823 (1997)
Luo, J., Su, F., Chen, D., Shiloh, A. & Gu, W. Deacetylation of p53 modulates its effect on cell growth and apoptosis. Nature 408, 377–381 (2000)
D'Andrea, A. & Pellman, D. Deubiquitinating enzymes: a new class of biological regulators. Crit. Rev. Biochem. Mol. Biol. 35, 337–352 (1998)
Chung, C. H. & Baek, S. H. Deubiquitinating enzymes: their diversity and emerging roles. Biochem. Biophys. Res. Commun. 266, 633–640 (1999)
Wilkinson, K. D. Ubiquitination and deubiquitination: targeting of proteins for degradation by the proteasome. Semin. Cell Dev. Biol. 11, 141–148 (2000)
Slingerland, J. & Pagano, M. Regulation of the cdk inhibitor p27 and its deregulation in cancer. J. Cell Physiol. 183, 10–17 (2000)
Seavey, S. E., Holubar, M., Saucedo, L. J. & Perry, M. E. The E7 oncoprotein of human papillomavirus type 16 stabilizes p53 through a mechanism independent of p19 (ARF). J. Virol. 73, 7590–7598 (1999)
Tolbert, D., Lu, X., Yin, C., Tantama, M. & Van Dyke, T. p19ARF is dispensable for oncogenic stress-induced p53-mediated apoptosis and tumor suppression in vivo. Mol. Cell. Biol. 22, 370–377 (2002)
Luo, J. et al. Negative control of p53 by Sir2α promotes cell survival under stress. Cell 107, 137–148 (2001)
Rodriguez, M. S., Desterro, J. M. P., Lain, S., Lane, D. P. & Hay, R. T. Multiple C-terminal lysine residues target p53 for ubiquitin-proteasome-mediated degradation. Mol. Cell. Biol. 20, 8458–8467 (2000)
Acknowledgements
We thank R. Baer, R. Dalla-Favera, B. Tycko and T. Ludwig for critical discussions; we also thank many colleges in the field for providing antibodies, cell lines and plasmids, and other members of W.G.’s laboratory for sharing unpublished data and critical comments. This work was supported in part by grants from Avon Foundation, the Stewart Trust, the Irma T. Hirschl Trust and NIH/NCI to W.G., who is also a Leukemia and Lymphoma Society Scholar.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare that they have no competing financial interests
Rights and permissions
About this article
Cite this article
Li, M., Chen, D., Shiloh, A. et al. Deubiquitination of p53 by HAUSP is an important pathway for p53 stabilization. Nature 416, 648–653 (2002). https://doi.org/10.1038/nature737
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/nature737
This article is cited by
-
Stabilization of Pin1 by USP34 promotes Ubc9 isomerization and protein sumoylation in glioma stem cells
Nature Communications (2024)
-
Backbone 1H, 13C and 15N resonance assignment of the ubiquitin specific protease 7 catalytic domain (residues 208–554) in complex with a small molecule ligand
Biomolecular NMR Assignments (2024)
-
The Function of Deubiquitinating Enzymes in Arabidopsis: Recent Progress of Ubiquitin-Specific Proteases (UBPs)
Journal of Plant Biology (2024)
-
EOAI, a ubiquitin-specific peptidase 5 inhibitor, prevents non-small cell lung cancer progression by inducing DNA damage
BMC Cancer (2023)
-
Targeting ubiquitin specific proteases (USPs) in cancer immunotherapy: from basic research to preclinical application
Journal of Experimental & Clinical Cancer Research (2023)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.